Anticipate, Target and Characterize: MS²-anticipated C-glycosylflavones from Erythrococca anomala
Planta Medica International Open · 01.12.2021 · 8 (03) · e131-e142
DOI: 10.1055/a-1576-4351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica International Open, erschienen am 01.12.2021. Verfasst von Tapé Kouamé und 15 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We herein report on the first chemical assessment of Erythrococca anomala (Juss. ex Poir.) Prain (Euphorbiaceae), a genus that was – to the best of our knowledge – not studied yet from a phytochemical perspective. A molecular networking strategy was implemented to rapidly identify the known specialized metabolites from untargeted MS/MS analyses of E. anomala leaves ethanolic extract. This strategy allowed for the identification of diverse C-glycosyl flavones and a cursory examination of MS/MS spectra could extend the GNPS-provided annotation to pinpoint the structural novelty of further derivatives. The isolation of the sought-after structures could be streamlined based on MS-guidance and their structures, determined through extensive NMR analyses, displayed structural features in line with MS²-based predictions. Anticipating sharp structural features at an early stage of the dereplication process through a critical assessment of the tandem mass spectrometric landmarks was essential to embark on the isolation of the newly reported structures owing to the elevated number of flavonoid glycosides isomers thereof formerly known, which would have deterred us from isolating them without the support of additional tandem mass spectrometric information. The isolation of the main components of the ethanolic extract completed the currently provided chemical report on E. anomala, also resulting in the description of a new phenylethanoid derivative (3) and of a new orcinol-based dimer (4). Anomaloflavone (1) exhibit significant activities with minimal inhibitory concentration values of 25 µg/mL against Staphylococcus aureus and Mycobacterium smegmatis while failing to exert an antibacterial activity against Pseudomonas aeruginosa, while being devoid of cytotoxicity against SiHa cells.
Zitieren
APA
Kouamé, T., Okpekon, T., Bony, N. F., Ferron, S., Bonnaffé, D., Vanheuverzwijn, J., Zhou, Z., Fontaine, V., N’Tamon, A. D., Gallard, J., Leblanc, K., Jullian, J., Miel, C., Champy, P., Beniddir, M. A., & Pogam, P. L. (2021). Anticipate, Target and Characterize: MS²-anticipated C-glycosylflavones from Erythrococca anomala. Planta Medica International Open, 8(03), e131-e142. https://doi.org/10.1055/a-1576-4351
Vancouver
Kouamé T, Okpekon T, Bony NF, Ferron S, Bonnaffé D, Vanheuverzwijn J, et al. Anticipate, Target and Characterize: MS²-anticipated C-glycosylflavones from Erythrococca anomala. Planta Medica International Open. 2021;8(03):e131-e142. doi:10.1055/a-1576-4351
BibTeX
@article{Kouam2021,
author = {Kouamé, Tapé and Okpekon, Timothée and Bony, Nicaise F. and Ferron, Solenn and Bonnaffé, David and Vanheuverzwijn, Jérôme and Zhou, Zhiyu and Fontaine, Véronique and N’Tamon, Amon Diane and Gallard, Jean-François and Leblanc, Karine and Jullian, Jean-Christophe and Miel, Corto and Champy, Pierre and Beniddir, Mehdi A. and Pogam, Pierre Le},
title = {Anticipate, Target and Characterize: MS²-anticipated C-glycosylflavones from Erythrococca anomala},
journal = {Planta Medica International Open},
year = {2021},
volume = {8},
number = {03},
pages = {e131--e142},
doi = {10.1055/a-1576-4351}
}
EUVIMED